Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 242

1.

Down-Regulation of miR-186 Correlates with Poor Survival in de novo Acute Myeloid Leukemia.

Zhang TJ, Wang YX, Yang DQ, Yao DM, Yang L, Zhou JD, Deng ZQ, Wen XM, Guo H, Ma JC, Lin J, Qian J.

Clin Lab. 2016;62(1-2):113-20.

PMID:
27012040
2.

Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia.

Liu L, Chen R, Zhang Y, Fan W, Xiao F, Yan X.

Diagn Pathol. 2015 Jul 17;10:109. doi: 10.1186/s13000-015-0345-6.

3.

Clinical significance of up-regulated ID1 expression in Chinese de novo acute myeloid leukemia.

Zhou JD, Yang L, Zhu XW, Wen XM, Yang J, Guo H, Chen Q, Yao DM, Ma JC, Lin J, Qian J.

Int J Clin Exp Pathol. 2015 May 1;8(5):5336-44. eCollection 2015.

4.

High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.

Zhang TJ, Lin J, Zhou JD, Li XX, Zhang W, Guo H, Xu ZJ, Yan Y, Ma JC, Qian J.

Gene. 2018 Jan 15;640:79-85. doi: 10.1016/j.gene.2017.10.034. Epub 2017 Oct 12.

PMID:
29032147
5.

Prognostic value of miR-96 in patients with acute myeloid leukemia.

Zhao J, Lu Q, Zhu J, Fu J, Chen YX.

Diagn Pathol. 2014 Mar 29;9:76. doi: 10.1186/1746-1596-9-76.

6.

Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.

Becker H, Marcucci G, Maharry K, Radmacher MD, Mrózek K, Margeson D, Whitman SP, Wu YZ, Schwind S, Paschka P, Powell BL, Carter TH, Kolitz JE, Wetzler M, Carroll AJ, Baer MR, Caligiuri MA, Larson RA, Bloomfield CD.

J Clin Oncol. 2010 Feb 1;28(4):596-604. doi: 10.1200/JCO.2009.25.1496. Epub 2009 Dec 21.

7.

Low miR-34c expression is associated with poor outcome in de novo acute myeloid leukemia.

Yang DQ, Zhou JD, Wang YX, Deng ZQ, Yang J, Yao DM, Qian Z, Yang L, Lin J, Qian J.

Int J Lab Hematol. 2017 Feb;39(1):42-50. doi: 10.1111/ijlh.12566. Epub 2016 Aug 31.

PMID:
27577964
8.

The clinical characteristics and prognostic significance of MN1 gene and MN1-associated microRNA expression in adult patients with de novo acute myeloid leukemia.

Xiang L, Li M, Liu Y, Cen J, Chen Z, Zhen X, Xie X, Cao X, Gu W.

Ann Hematol. 2013 Aug;92(8):1063-9. doi: 10.1007/s00277-013-1729-x. Epub 2013 Mar 21.

PMID:
23515710
9.

The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.

Díaz-Beyá M, Brunet S, Nomdedéu J, Pratcorona M, Cordeiro A, Gallardo D, Escoda L, Tormo M, Heras I, Ribera JM, Duarte R, de Llano MP, Bargay J, Sampol A, Nomdedeu M, Risueño RM, Hoyos M, Sierra J, Monzo M, Navarro A, Esteve J; Cooperative AML group CETLAM.

Oncotarget. 2015 Oct 13;6(31):31613-27. doi: 10.18632/oncotarget.5148.

10.

Double CEBPA mutations are prognostically favorable in non-M3 acute myeloid leukemia patients with wild-type NPM1 and FLT3-ITD.

Wen XM, Lin J, Yang J, Yao DM, Deng ZQ, Tang CY, Xiao GF, Yang L, Ma JC, Hu JB, Qian W, Qian J.

Int J Clin Exp Pathol. 2014 Sep 15;7(10):6832-40. eCollection 2014.

11.

Overexpression of miR-378 is frequent and may affect treatment outcomes in patients with acute myeloid leukemia.

Qian J, Lin J, Qian W, Ma JC, Qian SX, Li Y, Yang J, Li JY, Wang CZ, Chai HY, Chen XX, Deng ZQ.

Leuk Res. 2013 Jul;37(7):765-8. doi: 10.1016/j.leukres.2013.03.014. Epub 2013 Apr 11.

PMID:
23582927
12.

Prognostic value of miR-29a expression in pediatric acute myeloid leukemia.

Zhu C, Wang Y, Kuai W, Sun X, Chen H, Hong Z.

Clin Biochem. 2013 Jan;46(1-2):49-53. doi: 10.1016/j.clinbiochem.2012.09.002. Epub 2012 Sep 12.

PMID:
22981932
13.

[CEBPA gene mutation analysis in acute myeloid leukemia].

Han C, Lin D, Ai XF, Wang F, Sun HY, Wang M, Mi YC, Wang JX, Ru K.

Zhonghua Xue Ye Xue Za Zhi. 2013 Jul;34(7):566-71. doi: 10.3760/cma.j.issn.0253-2727.2013.07.002. Chinese.

PMID:
23906447
14.

RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures.

Mendler JH, Maharry K, Radmacher MD, Mrózek K, Becker H, Metzeler KH, Schwind S, Whitman SP, Khalife J, Kohlschmidt J, Nicolet D, Powell BL, Carter TH, Wetzler M, Moore JO, Kolitz JE, Baer MR, Carroll AJ, Larson RA, Caligiuri MA, Marcucci G, Bloomfield CD.

J Clin Oncol. 2012 Sep 1;30(25):3109-18. doi: 10.1200/JCO.2011.40.6652. Epub 2012 Jul 2.

15.

Overexpression of miR-216b: Prognostic and predictive value in acute myeloid leukemia.

Zhang TJ, Wu DH, Zhou JD, Li XX, Zhang W, Guo H, Ma JC, Deng ZQ, Lin J, Qian J.

J Cell Physiol. 2018 Apr;233(4):3274-3281. doi: 10.1002/jcp.26171. Epub 2017 Sep 28.

PMID:
28884855
16.

Down-regulation of GPX3 is associated with favorable/intermediate karyotypes in de novo acute myeloid leukemia.

Zhou JD, Wen XM, Zhang YY, Yang L, Ma YJ, Ma JC, Yang J, Guo H, Yao DM, Lin J, Qian J.

Int J Clin Exp Pathol. 2015 Mar 1;8(3):2384-91. eCollection 2015.

17.

Down-regulation of pseudogene Vimentin 2p is associated with poor outcome in de novo acute myeloid leukemia.

Zhai LL, Zhou J, Zhang J, Tang X, Zhou LY, Yin JY, Vanessa MD, Peng W, Lin J, Deng ZQ.

Cancer Biomark. 2017;18(3):305-312. doi: 10.3233/CBM-160247.

PMID:
28106537
18.

CEBPA gene mutations in Egyptian acute myeloid leukemia patients: impact on prognosis.

Awad MM, Aladle DA, Abousamra NK, Elghannam DM, Fawzy IM.

Hematology. 2013 Mar;18(2):61-8. doi: 10.1179/1607845412Y.0000000032. Epub 2012 Sep 14.

PMID:
22990006
19.

Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia.

Tian C, Zhang L, Li X, Zhang Y, Li J, Chen L.

Cancer Biomark. 2018;22(2):209-215. doi: 10.3233/CBM-170657.

PMID:
29689705
20.

Dysregulation of miR-200s clusters as potential prognostic biomarkers in acute myeloid leukemia.

Zhou JD, Zhang LC, Zhang TJ, Gu Y, Wu DH, Zhang W, Ma JC, Wen XM, Guo H, Lin J, Qian J.

J Transl Med. 2018 May 21;16(1):135. doi: 10.1186/s12967-018-1494-7.

Supplemental Content

Support Center